Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000876493) titled 'A 12-participant study in depressed patients collecting CSF (Cerebrospinal fluid) to study the pharmacodynamic biomarkers of EVX-301 (L-5 Hydroxytryptophan in Saline) over a 24 hour infusion period' on Aug. 12.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Factorial
Type of endpoint: Safety/efficacy
Primary Sponsor: Evecxia Therapeutics, Inc.
Condition:
Depression
Depression
Mental Health - Depression
Intervention:
CSF Sampling Process is as follows:
Anaesthesia-trained staff will perform the Lumber Punctu...